(S (NP-SBJ (NN HIV-1) (NN Nef) (NN protein)) (VP (VBZ inhibits) (NP (NP (DT the) (NN recruitment)) (PP (IN of) (NP (NP (NN AP-1) (JJ DNA-binding) (NN activity)) (PP (IN in) (NP (JJ human) (NNS T-cells))))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1) (JJ long) (JJ terminal) (NN repeat)) (, ,) (NP (NN HIV-1-LTR)) (, ,)) (VP (VBZ contains) (NP (NP (VBG binding) (NNS sites)) (PP (IN for) (NP (NP (JJ several) (JJ cellular) (NN transcription) (NNS factors)) (SBAR (WHNP-13 (WDT which)) (S (NP-SBJ (-NONE- *T*-13)) (VP (VBP contribute) (PP (TO to) (NP (NN HIV-1) (NN gene) (NN expression)))))))))) (. .))
(S (NP-SBJ (NP (PRP$ Our) (JJ previous) (NNS studies)) (PP (IN on) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (DT the) (JJ HIV-1-encoded) (NN Nef) (NN protein)))))) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ (NN Nef)) (VP (MD may) (VP (VB be) (NP-PRD (DT an) (NN inhibitor) (NN HIV-1) (NN transcription))))))) (. .))
(S (S (NP-SBJ (-NONE- *)) (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP-SBJ (NN Nef)) (VP (VBZ affects) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (JJ cellular) (NNS factors))) (VP (VBN implicated) (NP (-NONE- *)) (PP (IN in) (NP (NN HIV-1) (NN regulation))))))))))) (, ,) (NP-SBJ-14 (NP (JJ 32P-labeled) (NNS oligonucleotides)) (VP (VBG corresponding) (PP (TO to) (NP (DT the) (VBG binding) (NNS sites))))) (VP (VBD were) (VP (VBN incubated) (NP (-NONE- *-14)) (PP (IN with) (NP (NP (JJ nuclear) (NNS extracts)) (VP (VBN prepared) (NP (-NONE- *)) (PP (IN from) (NP (NP (JJ Nef-expressing) (NN T-cell) (NNS lines)) (SBAR (WHNP-15 (WDT that)) (S (NP-SBJ-16 (-NONE- *T*-15)) (VP (VP-COOD (VP (VBD were) (RB not) (VP (VBN stimulated) (NP (-NONE- *-16)))) (CC or) (VP (VBD were) (VP (VBN stimulated) (NP (-NONE- *-16))))) (PP (IN with) (NP (NN T-cell) (NNS mitogens))))))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ (NN Nef)) (VP (VBD inhibited) (NP (NP (DT the) (NN recruitment)) (PP (IN of) (NP (NP (NN AP-1) (JJ DNA-binding) (NN activity)) (PP (IN in) (NP (JJ mitogen-stimulated) (JJ human) (NNS T-cells)))))))))) (. .))
(S (ADVP (RB Additionally)) (, ,) (NP-SBJ-18 (NN Nef) (NN expressing) (NNS cells)) (VP (VBD were) (VP (ADVP-TMP (RB transiently)) (VBN transfected) (NP (-NONE- *-18)) (PP (IN with) (NP (NP (DT a) (NN plasmid)) (SBAR (WHPP-19 (IN in) (WHNP (WDT which))) (S (NP-SBJ-20 (NN HIV-1) (NN AP-1) (NN DNA) (NN recognition) (NNS sequences)) (VP (VBD were) (VP (VBN cloned) (NP (-NONE- *-20)) (ADVP (RB downstream) (PP (IN of) (NP (DT the) (NP (NP (NN chloramphenicol) (NN acetyltransferase)) (PRN (-LRB- -LRB-) (NP (NN CAT)) (-RRB- -RRB-))) (NN gene)))) (PP (-NONE- *T*-19)))))))))) (. .))
(S (NP-SBJ-21 (NP (JJ Mitogen-mediated) (JJ transcriptional) (NN activation)) (PP (IN of) (NP (DT the) (NN CAT) (NN gene))) (PP (IN in) (NP (DT this) (NN construct)))) (VP (VBD was) (VP (VBN inhibited) (NP (-NONE- *-21)) (PP-COOD (PP (IN in) (NP (JJ Nef-expressing) (NNS cells))) (CC but) (PP (RB not) (IN in) (NP (NN control) (NNS cells)))))) (. .))
(S (NP-SBJ (DT These) (NNS studies)) (VP (VBP suggest) (SBAR (IN that) (S (PP (, ,) (S (NP-SBJ-23 (-NONE- *-22)) (VP (IN by) (NP (VBG inhibiting) (NN AP-1))))) (NN activation) (NP-SBJ-22 (, ,)) (VP (NN Nef) (VP (MD may) (NP (VB play) (DT a)) (PP (NN role) (S (NP-SBJ (-NONE- *-23)) (VP (IN in) (NP (NP (VBG regulating) (NN HIV-1) (NN gene)) (PP (NN expression) (NP (IN in) (JJ infected)))))))))))) (NNS T-cells))
